Trial Profile
Generic valsartan versus original valsartan in metabolic syndrome patients with mild-to-moderate hypertension
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 23 May 2012
Price :
$35
*
At a glance
- Drugs Valsartan (Primary)
- Indications Hypertension; Metabolic syndrome
- Focus Therapeutic Use
- 23 May 2012 New trial record
- 29 Apr 2012 Results presented at the 22nd European Meeting on Hypertension.